Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Viemed Healthcare (VMD) Gross Profit (2018 - 2025)

Historic Gross Profit for Viemed Healthcare (VMD) over the last 8 years, with Q3 2025 value amounting to $41.3 million.

  • Viemed Healthcare's Gross Profit rose 2029.04% to $41.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $147.5 million, marking a year-over-year increase of 1417.99%. This contributed to the annual value of $133.2 million for FY2024, which is 1810.56% up from last year.
  • Viemed Healthcare's Gross Profit amounted to $41.3 million in Q3 2025, which was up 2029.04% from $36.7 million recorded in Q2 2025.
  • Over the past 5 years, Viemed Healthcare's Gross Profit peaked at $41.3 million during Q3 2025, and registered a low of $17.6 million during Q2 2021.
  • For the 5-year period, Viemed Healthcare's Gross Profit averaged around $27.1 million, with its median value being $26.1 million (2023).
  • Per our database at Business Quant, Viemed Healthcare's Gross Profit tumbled by 3202.07% in 2021 and then surged by 4115.75% in 2023.
  • Quarter analysis of 5 years shows Viemed Healthcare's Gross Profit stood at $19.7 million in 2021, then grew by 16.45% to $22.9 million in 2022, then soared by 40.25% to $32.1 million in 2023, then grew by 12.54% to $36.1 million in 2024, then rose by 14.41% to $41.3 million in 2025.
  • Its Gross Profit was $41.3 million in Q3 2025, compared to $36.7 million in Q2 2025 and $33.3 million in Q1 2025.